Table: Pharmarise Holdings -Q1 group results

Pharmarise Holdings

17/09/2026 08:30

    Sept 17 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2026        Aug 31, 2025     May 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             17.24               16.75            70.60    
                 (+2.9 pct)          (+10.0 pct)      (+1.6 pct)  
  Operating        68 mln              152 mln            1.01    
                 (-54.8 pct)        (+188.5 pct)      (+3.5 pct)  
  Recurring        79 mln              115 mln          736 mln   
                 (-31.3 pct)        (+399.1 pct)      (+2.9 pct)  
  Net            loss 36 mln         loss 18 mln        11 mln    
                                                      (-90.0 pct) 
  EPS           loss 3.20 yen       loss 1.62 yen      0.99 yen   
  Ann Div                             14.00 yen        14.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T